Treatment of Anxiety During PregnancyEffects of Psychotropic Drug Treatment on the Developing Fetus

被引:0
|
作者
Caroline McGrath
Anne Buist
Trevor R. Norman
机构
[1] University of Melbourne,Department of Psychiatry
[2] University of Melbourne,undefined
[3] Repatriation Medical Centre,undefined
来源
Drug Safety | 1999年 / 20卷
关键词
Diazepam; Adis International Limited; Fluoxetine; Imipramine; Panic Disorder;
D O I
暂无
中图分类号
学科分类号
摘要
Pregnancy is a time of great emotional change for a woman, producing increased stress and anxiety. Medication may be required for the treatment of anxiety disorders at this time. Given the fact that psychotropic drugs readily cross the placenta and could have important implications for the developing fetus, it is necessary to balance the possible effects of medication against the potential effects to both the mother and fetus if the anxiety disorder is left untreated.
引用
收藏
页码:171 / 186
页数:15
相关论文
共 50 条
  • [41] PSYCHOTROPIC MEDICATIONS DURING PREGNANCY - RISK TO THE FETUS - REPLY
    KOREN, G
    PASTUSZAK, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (18): : 2178 - 2178
  • [42] An examination of psychotropic drug treatment for children with serious emotional disturbance
    Hallfors, D
    Fallon, T
    Watson, K
    JOURNAL OF EMOTIONAL AND BEHAVIORAL DISORDERS, 1998, 6 (01) : 56 - 64
  • [43] Psychotropic medication involved in intentional drug overdose: implications for treatment
    Corcoran, Paul
    Heavey, Breda
    Griffin, Eve
    Perry, Ivan J.
    Arensman, Ella
    NEUROPSYCHIATRY, 2013, 3 (03) : 285 - 293
  • [44] SOME CHANGES IN SERUM DURING TREATMENT WITH PSYCHOTROPIC DRUGS
    BENGZON, A
    HIPPIUS, H
    KANIG, K
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1966, 143 (04) : 369 - &
  • [45] Psychotropic medication during endocrine treatment for breast cancer
    Geertruida H. de Bock
    Regina F. Musters
    H. Jens Bos
    Caroline P. Schröder
    Marian J. E. Mourits
    Lolkje T. W. de Jong-van den Berg
    Supportive Care in Cancer, 2012, 20 : 1533 - 1540
  • [46] On the pathophysiology of weight regulation during treatment with psychotropic drugs
    Kraus, T
    Zimmermann, U
    Schuld, A
    Haack, M
    Hinze-Selch, D
    Pollmächer, T
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2001, 69 (03) : 116 - 137
  • [47] Psychotropic medication during endocrine treatment for breast cancer
    de Bock, Geertruida H.
    Musters, Regina F.
    Bos, H. Jens
    Schroder, Caroline P.
    Mourits, Marian J. E.
    de Jong-van den Berg, Lolkje T. W.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (07) : 1533 - 1540
  • [48] Sexual function and dysfunction during treatment with psychotropic medications
    Balon, R
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (11) : 1488 - 1489
  • [49] Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of PregnancyEffects on the Infant
    Hedvig Nordeng
    Olav Spigset
    Drug Safety, 2005, 28 : 565 - 581
  • [50] SOMATOSENSORY EVOKED-POTENTIALS AS INDICATORS OF ALTERED CEREBRAL EXCITABILITY DURING PSYCHOTROPIC-DRUG TREATMENT
    FORSTL, H
    ZAGORSKI, A
    POHLMANNEDEN, B
    BIOLOGICAL PSYCHIATRY, 1991, 29 (04) : 397 - 402